I spoke to Terry in investor's relations today. Dr. Moro told him right before he left for Prague that the science for the Recaf is finished! That tells me that Abbott is satisfied with the test as is.
When asked about other news we'll be seeing shortly, he mentioned Biocurex was in the final stages of finalizing a licensing agreement with a recognized company associated with cancer, but it is not a pharma. Anyone care to speculate? When asked about what's next, he told me he doesn't know for sure, but the next logical step would be trials. He said that Biocurex has been working with Munich or Moscow University, but I don't think he knew on what.